GLP1R and myocardial infarction: GLP-1 RAs have been found to improve body weight, blood pressure (BP), lipid profile levels, and myocardial infarction (MI) outcomes even in nondiabetic patients without increasing the risk of hypoglycemic events (11, 16–20).